Home/Filings/4/0001209191-18-051063
4//SEC Filing

Hendry W Myron 4

Accession 0001209191-18-051063

CIK 0000875159other

Filed

Sep 13, 8:00 PM ET

Accepted

Sep 14, 4:10 PM ET

Size

32.0 KB

Accession

0001209191-18-051063

Insider Transaction Report

Form 4
Period: 2018-09-12
Hendry W Myron
Chief Platform Officer
Transactions
  • Disposition to Issuer

    Employee Stock Option (Right to buy)

    2018-09-12$57.60/sh66,778$3,846,4130 total
    Exercise: $34.64From: 2019-02-28Exp: 2026-02-28Common Shares (66,778 underlying)
  • Disposition to Issuer

    Common Shares

    2018-09-12$57.60/sh4,929$283,9100 total
  • Disposition to Issuer

    Employee Stock Option (Right to buy)

    2018-09-12$57.60/sh15,474$891,3020 total
    Exercise: $42.31From: 2021-02-28Exp: 2028-02-28Common Shares (15,474 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to buy)

    2018-09-12$57.60/sh29,070$1,674,4320 total
    Exercise: $30.40From: 2017-02-28Exp: 2024-02-28Common Shares (29,070 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2018-09-12$57.60/sh3,293$189,6770 total
    Common Shares (3,293 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2018-09-12$57.60/sh3,782$217,8430 total
    Common Shares (3,782 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to buy)

    2018-09-12$57.60/sh40,323$2,322,6050 total
    Exercise: $20.61From: 2015-02-28Exp: 2022-02-28Common Shares (40,323 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to buy)

    2018-09-12$57.60/sh60,883$3,506,8610 total
    Exercise: $36.20From: 2018-02-28Exp: 2025-02-28Common Shares (60,883 underlying)
  • Disposition to Issuer

    Dividend Equivalent Rights

    2018-09-12$57.60/sh29.96$1,7260 total
    Common Shares (29.96 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to buy)

    2018-09-12$57.60/sh29,977$1,726,6750 total
    Exercise: $28.64From: 2016-02-28Exp: 2023-02-28Common Shares (29,977 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to buy)

    2018-09-12$57.60/sh29,674$1,709,2220 total
    Exercise: $40.49From: 2020-02-28Exp: 2027-02-28Common Shares (29,674 underlying)
  • Disposition to Issuer

    Dividend Equivalent Rights

    2018-09-12$57.60/sh100.55$5,7920 total
    Common Shares (100.55 underlying)
Footnotes (9)
  • [F1]Disposed of following the completion of the merger (the "Merger") described in the Agreement and Plan of Merger, dated as of March 5, 2018, by and among AXA SA, Camelot Holdings Ltd. and the Issuer. At the effective time of the Merger, each issued and outstanding common share of XL Group Ltd was automatically cancelled and converted into the right to receive $57.60 in cash (the "Merger Consideration").
  • [F2]Includes all common shares held directly by the Reporting Person immediately prior to the Merger and which were automatically cancelled and converted into the right to receive the Merger Consideration.
  • [F3]At the effective time of the Merger, each option to purchase common shares granted by XL Group Ltd outstanding and unexercised immediately prior to the effective time of the Merger (whether or not vested or exercisable) vested in full, was cancelled and was converted into the right to receive an amount in cash equal to the excess, if any, of the Merger Consideration over the per share exercise price of such option, multiplied by the number of common shares subject to such option immediately prior to the effective time of the Merger.
  • [F4]Each restricted stock unit represents a contingent right to receive one common share.
  • [F5]At the effective time of the Merger, each restricted stock unit granted by XL Group Ltd outstanding immediately prior to the effective time of the Merger (whether or not vested) vested in full, was automatically cancelled and converted into the right to receive the Merger Consideration.
  • [F6]At the time of grant, restricted stock units granted on February 28, 2017 were scheduled to vest in three equal annual installments on each anniversary of the grant date (February 28, 2018, 2019 and 2020).
  • [F7]The dividend equivalent rights accrued when and as dividends were paid on common shares. Each dividend equivalent right is the economic equivalent of one common share.
  • [F8]At the effective time of the Merger, each dividend equivalent right accrued and outstanding prior to the effective time of the Merger (whether or not vested) vested in full, was automatically cancelled and converted into the right to receive the Merger Consideration.
  • [F9]At the time of grant, restricted stock units granted on February 28, 2018 were scheduled to vest in three equal annual installments on each anniversary of the grant date (February 28, 2019, 2020 and 2021).

Issuer

XL GROUP LTD

CIK 0000875159

Entity typeother

Related Parties

1
  • filerCIK 0001307947

Filing Metadata

Form type
4
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 4:10 PM ET
Size
32.0 KB